Welcome to our dedicated page for Bioceres Crop Solutions news (Ticker: BIOX), a resource for investors and traders seeking the latest updates and insights on Bioceres Crop Solutions stock.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) regularly issues news and updates that reflect its role in agricultural biotechnology, crop inputs and sustainable farming practices. Company announcements frequently describe new developments in its crop protection, seed and integrated products, and crop nutrition segments, as well as progress on its HB4 technology platform and biological solutions.
Investors and industry followers can use this news feed to monitor Bioceres’ financial performance, including quarterly and full-year results prepared under IFRS. Earnings releases typically cover revenues by segment, gross profit and margin trends, operating profit or loss, net income or loss and Adjusted EBITDA, along with commentary on working capital, cash flow and cost structure adjustments.
Bioceres’ news also highlights technology and regulatory milestones. Recent communications include the EPA registration of the Rinotec insecticide and nematicide platform in the United States, commercialization approvals in Brazil, and patent protection for HB4 wheat in the U.S. until 2042. The company has also reported a strategic collaboration with the Colorado Wheat Research Foundation to develop and commercialize HB4 wheat in the United States under an open licensing model.
Corporate governance and financing developments appear in the company’s updates as well, such as changes to the Board of Directors and senior management, amendments to note purchase agreements, and disclosures related to noteholder communications and litigation. By following this page, readers can track how Bioceres communicates its segment performance, capital structure actions and progress on its biotech and biological platforms across key agricultural markets.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced a conference call scheduled for May 11, 2023, at 8:30 a.m. ET to discuss its financial results for the third quarter ended March 31, 2023. The call will be hosted by key executives, including CEO Federico Trucco and CFO Enrique Lopez Lecube, and will include a presentation accessible via the company's investor relations website. Investors can participate using a toll-free number or through an international dial-in link. A replay of the call will be available until May 18, 2023. Bioceres is focused on crop productivity solutions aimed at promoting carbon neutrality in agriculture, leveraging its unique biotech platform and the HB4 program for enhanced farmer support and output traceability.
Arcadia Biosciences reported a remarkable 47% increase in total revenues for 2022, reaching $9.96 million, driven by strong sales of GoodWheat pasta and coconut water. Operating expenses declined by 32% to $28.8 million, significantly reducing cash burn. The launch of GoodWheat pasta exceeded expectations, distributing in over 1,200 stores within seven months. The company also unveiled Project Greenfield, a three-year plan to enhance profitability and product expansion. Despite the progress, net losses for the year increased to $15.4 million, highlighting ongoing challenges.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will participate in the 35th Annual Roth Conference from March 12-14, 2023, at The Ritz Carlton Laguna Niguel in Dana Point, California. CEO Federico Trucco and CFO Enrique Lopez Lecube will attend to discuss the recent fiscal second quarter 2023 financial results, HB4 Wheat 2022/23 results, and regulatory approvals. Trucco will also join the 'AG Biologicals and Gene Editing' panel on March 13 at 1:30 PM PT. For more details, visit the Roth Conference website.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced that Brazil's National Biosafety Commission has approved the commercialization and cultivation of HB4 Wheat. This follows an earlier approval for food and feed use in November 2021. The decision not only opens the Brazilian market but also allows for further collaboration with EMBRAPA to develop local wheat varieties. HB4 Wheat can increase yields by over 40% in water-stressed areas and is expected to add $15-$20 million in EBITDA by FY24. Brazil plants 2-3 million hectares of wheat annually, contributing significantly to South America's wheat acreage.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported a 7% decline in total revenues for Q2 FY23, totaling $94.4 million, primarily due to severe drought conditions in Argentina, which halved wheat output. However, sales in North America partially offset losses. The adjusted EBITDA stood at $10.3 million, a decrease of 43% YoY, with gross profit down 28%. Despite adverse weather, the HB4 Wheat technology showed a 43% yield improvement versus conventional varieties, and HB4 Soy sales were initiated in Brazil. Management expects a resumption of growth in the latter half of the fiscal year as conditions improve.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will host a conference call on February 9, 2023, at 8:30 a.m. ET, to discuss its second-quarter results ending December 31, 2022. The call, led by CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of Investor Relations Paula Savanti, will follow a press release with detailed financial data. Interested participants can access the call via toll-free and international dial-in numbers or through a live webcast, with a replay available until February 14, 2023.
Bioceres is focused on sustainable agriculture and offers innovative crop productivity solutions.
The merger between Calyxt and Cibus aims to create a leading entity in precision gene editing and sustainable agriculture. Under the all-stock deal, Calyxt shareholders will retain approximately 5% of the new company, which will operate under the name Cibus Inc. Key applications include enhancing productivity traits in seeds and developing renewable low-carbon ingredients. The merger supports a strong collaboration pipeline with major seed companies, with three productivity traits expected to launch in early 2023. Both companies anticipate significant regulatory developments that could enhance market opportunities.
FAQ
What is the current stock price of Bioceres Crop Solutions (BIOX)?
What is the market cap of Bioceres Crop Solutions (BIOX)?
